1. Home
  2. NNNN vs CCB Comparison

NNNN vs CCB Comparison

Compare NNNN & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • CCB
  • Stock Information
  • Founded
  • NNNN 2021
  • CCB 1997
  • Country
  • NNNN Germany
  • CCB United States
  • Employees
  • NNNN N/A
  • CCB N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CCB Major Banks
  • Sector
  • NNNN Health Care
  • CCB Finance
  • Exchange
  • NNNN Nasdaq
  • CCB Nasdaq
  • Market Cap
  • NNNN 2.2B
  • CCB 1.8B
  • IPO Year
  • NNNN 2025
  • CCB 2018
  • Fundamental
  • Price
  • NNNN $23.92
  • CCB $106.04
  • Analyst Decision
  • NNNN
  • CCB Strong Buy
  • Analyst Count
  • NNNN 0
  • CCB 4
  • Target Price
  • NNNN N/A
  • CCB $113.75
  • AVG Volume (30 Days)
  • NNNN 76.5K
  • CCB 121.8K
  • Earning Date
  • NNNN 11-07-2025
  • CCB 10-27-2025
  • Dividend Yield
  • NNNN N/A
  • CCB N/A
  • EPS Growth
  • NNNN N/A
  • CCB 18.14
  • EPS
  • NNNN 0.06
  • CCB 3.25
  • Revenue
  • NNNN $8,185,146.00
  • CCB $336,394,000.00
  • Revenue This Year
  • NNNN N/A
  • CCB $83.27
  • Revenue Next Year
  • NNNN N/A
  • CCB $35.03
  • P/E Ratio
  • NNNN $442.46
  • CCB $32.84
  • Revenue Growth
  • NNNN 21.95
  • CCB 28.83
  • 52 Week Low
  • NNNN $5.18
  • CCB $59.40
  • 52 Week High
  • NNNN $55.65
  • CCB $119.22
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 35.64
  • CCB 47.92
  • Support Level
  • NNNN $26.05
  • CCB $101.92
  • Resistance Level
  • NNNN $30.65
  • CCB $109.28
  • Average True Range (ATR)
  • NNNN 2.72
  • CCB 3.68
  • MACD
  • NNNN -0.11
  • CCB 0.14
  • Stochastic Oscillator
  • NNNN 19.80
  • CCB 53.24

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

Share on Social Networks: